Study to Evaluate the Effect of an Ayurveda Compound in Recurrent Respiratory Infections

Phase 1

• Conditions: Health Condition 1: J989- Respiratory disorder, unspecified

• Registration Number: CTRI/2020/03/024389
• Lead Sponsor: ational Institute of Ayurveda Jaipur

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1)Children whose parents are willing to give consent for clinical trial.

2)Children aged between 01 to 05 years of either sex.

3) Children with recurrent respiratory infections.

Exclusion Criteria

1)Children suffering from major systemic illness necessitating long term treatment.

2)Children with evidence of malignancy, genetic or congenital anomaly.

3)Children with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S. creatinine >1.2mg/dl) uncontrolled pulmonary dysfunction (asthmatic and COPD patients)

4)Co-morbidity like TB, UTI and bleeding disorders etc.

5)H/o hypersensitivity to any of the trial drug or their ingredients.

6)Children who have completed participation in any other clinical trial during the past six months.

Study & Design

• Study Type: Interventional
• Study Design: Not specified